Find publications by Adaptive as well as our collaborators and partners who leverage our technologies.




Serial Assessment of Circulating T lymphocyte Phenotype and Receptor Repertoire During Treatment of Non-Muscle Invasive Bladder Cancer with Adoptive T Cell Immunotherapy

Wang X., et al.

  • September 2020

Exhaustion of tumour-infiltrating T-cell receptor repertoirediversity is an age-dependent indicator of immunological fit-ness independently predictive of clinical outcome in Burkittlymphoma

Rieken J., et al.

  • British Journal of Haematology
  • September 2020

CBFB-MYH11 fusion neoantigen enables T cell recognition and killing of acute myeloid leukemia

Biernacki MA., et al.

  • JCI
  • Journal of Clinical Investigation
  • September 2020

IL-32γ potentiates tumor immunity in melanoma

Gruber T., et al.

  • JCI Insight
  • September 2020

Radiation induces dynamic changes to the T cell repertoire in renal cell carcinoma patients

Integrated genomic analysis reveals mutated ELF3 as a potential gallbladder cancer vaccine candidate

Pandey A., et al.

  • Nature Communications
  • September 2020

A peripheral immune signature of responsiveness to PD-1 blockade in patients with classical Hodgkin lymphoma

Cader FZ., et al.

  • Nature Medicine
  • September 2020

De novo prediction of cancer-associated T cell receptors for noninvasive cancer detection

Beshnova D., et al.

  • Science Translational Medicine
  • September 2020

Epigenetic Suppression of Transgenic T-cell Receptor Expression via Gamma-Retroviral Vector Methylation in Adoptive Cell Transfer Therapy

Nowicki TS., et al.

  • Cancer Discovery
  • September 2020